These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38800046)

  • 41. Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature.
    Safa H; Johnson DH; Trinh VA; Rodgers TE; Lin H; Suarez-Almazor ME; Fa'ak F; Saberian C; Yee C; Davies MA; Tummala S; Woodman K; Abdel-Wahab N; Diab A
    J Immunother Cancer; 2019 Nov; 7(1):319. PubMed ID: 31753014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Myasthenia gravis and muscle atrophy].
    Sanadze AG; Gilvanova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):79-87. PubMed ID: 33728855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple sclerosis and Parkinson's disease: the two faces of neurodegeneration. Report of the first Greek case and review of the literature.
    Bougea A; Kapaki E; Paraskevas GP; Kilidireas K; Andreadou E
    Neurol Sci; 2015 Dec; 36(12):2281-5. PubMed ID: 26134747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coexistence of epilepsy, myasthenia gravis and psoriasis vulgaris.
    Kwan SY; Lin JH; Su MS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):153-7. PubMed ID: 10677928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Levodopa Response Varies in Pathologically Confirmed Parkinson's Disease: A Systematic Review.
    Pitz V; Malek N; Tobias ES; Grosset KA; Gentleman S; Grosset DG
    Mov Disord Clin Pract; 2020 Feb; 7(2):218-222. PubMed ID: 32071945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.
    Lu Y; Ran H; Yang W; Ma Q; Qiu L; Ou C; Chen P; Lin Z; Liu W
    Neuromuscul Disord; 2020 Jul; 30(7):534-538. PubMed ID: 32387283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myasthenia gravis with ocular involvement in older patients.
    Weizer JS; Lee AG; Coats DK
    Can J Ophthalmol; 2001 Feb; 36(1):26-33. PubMed ID: 11227387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudo-myasthenia gravis and thymic hyperplasia in Graves' disease.
    Nicolle MW
    Can J Neurol Sci; 1999 Aug; 26(3):201-3. PubMed ID: 10451743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysfunctional chemosensation in myasthenia gravis: a systematic review.
    Leon-Sarmiento FE; Leon-Ariza DS; Doty RL
    J Clin Neuromuscul Dis; 2013 Sep; 15(1):1-6. PubMed ID: 23965402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Achalasia and Cricopharyngeal Sphincter Dysfunction in a Patient With Myasthenia Gravis: A Case Report.
    Acharya S; Anwar S; Thapa K; Maroun R; Kilkenny TM
    Cureus; 2023 Jul; 15(7):e42575. PubMed ID: 37637514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coexistence of dentatorubral-pallidoluysian atrophy and Parkinson's disease: An autopsy case report.
    Kim SI; Kim H; Park JW; Choi JH; Kim HJ; Won JK; Jeon B; Park SH
    Neuropathology; 2021 Jun; 41(3):196-205. PubMed ID: 33851459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myasthenia Gravis as an Immune-Mediated Side Effect of Checkpoint Inhibitors.
    Heleno CT; Mustafa A; Gotera NA; Tesar A
    Cureus; 2021 Jul; 13(7):e16316. PubMed ID: 34277306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sarcoidosis in a case of MuSK-positive myasthenia gravis.
    Spengos K; Vassilopoulou S; Christou Y; Manta P
    Neuromuscul Disord; 2008 Nov; 18(11):890-1. PubMed ID: 18815037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thymolipomatous myasthenia gravis outcomes following thymectomy: a systematic review.
    Alghamdi ZM; Othman SA; Abdelmotaleb MS; Alreshaid F; Alomar A; Alaklbi M; Elbawab HY; Aljehani Y
    Interact Cardiovasc Thorac Surg; 2022 Mar; 34(4):584-589. PubMed ID: 35362060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of fatigue in Parkinson's disease: A longitudinal cohort study.
    Zhou X; Xiang Y; Song T; Zhao Y; Pan H; Xu Q; Chen Y; Sun Q; Wu X; Yan X; Guo J; Tang B; Lei L; Liu Z;
    Front Aging Neurosci; 2023; 15():1133705. PubMed ID: 36967819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ICF in neurology: functioning and disability in patients with migraine, myasthenia gravis and Parkinson's disease.
    Leonardi M; Meucci P; Ajovalasit D; Albanesi F; Cerniauskaite M; Invernizzi V; Lembo R; Quintas R; Sattin D; Carella F; Romito L; Soliveri P; Bussone G; D'amico D; Maggi L; Mantegazza R; Raggi A
    Disabil Rehabil; 2009; 31 Suppl 1():S88-99. PubMed ID: 19968543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of β2-Adrenergic Agonists on Risk of Parkinson's Disease in COPD: A Population-Based Study.
    Chen W; Sadatsafavi M; Tavakoli H; Samii A; Etminan M
    Pharmacotherapy; 2020 May; 40(5):408-415. PubMed ID: 32145705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimal change disease in a patient with myasthenia gravis: A case report.
    Tsai JL; Tsai SF
    Medicine (Baltimore); 2016 Sep; 95(39):e5008. PubMed ID: 27684864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.
    Sun J; Ludvigsson JF; Ingre C; Piehl F; Wirdefeldt K; Zagai U; Ye W; Fang F
    PLoS Med; 2022 Sep; 19(9):e1004092. PubMed ID: 36107840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case report: Coexistence of triple-seronegative myasthenia gravis and pathology-proven cryptogenic organizing pneumonia.
    Huang SQ; Wang B; Gao L; Wang M; Zhao HD; Shi JQ
    Front Neurol; 2023; 14():1295374. PubMed ID: 38046596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.